# Symbotic Inc.: financial statements, quarterly

SYM · Nasdaq · CIK 1837240 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 26

Pages: [Overview](/companies/sym.md) · [Financials](/companies/sym/financials.md) · [Filings](/companies/sym/filings.md) · [Insiders](/companies/sym/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sym/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [392](/filings/0001837240-24-000232.md) | [360](/filings/0001837240-25-000044.md) | [393](/filings/0001837240-25-000152.md) | [470](/filings/0001837240-25-000263.md) | [565](/filings/0001837240-24-000232.md) | [487](/filings/0001837240-26-000009.md) | [550](/filings/0001837240-26-000024.md) | [592](/filings/0001837240-26-000043.md) | [618 d](/filings/0001837240-25-000278.md) | [630](/filings/0001837240-26-000009.md) | [676](/filings/0001837240-26-000024.md) | [721](/filings/0001837240-26-000043.md) |
| Cost of revenue | $m | [333](/filings/0001837240-24-000232.md) | [296](/filings/0001837240-25-000044.md) | [363](/filings/0001837240-25-000152.md) | [415](/filings/0001837240-25-000263.md) | [468](/filings/0001837240-24-000232.md) | [406](/filings/0001837240-26-000009.md) | [439](/filings/0001837240-26-000024.md) | [480](/filings/0001837240-26-000043.md) | [499 d](/filings/0001837240-25-000278.md) | [497](/filings/0001837240-26-000009.md) | [527](/filings/0001837240-26-000024.md) | [560](/filings/0001837240-26-000043.md) |
| Gross profit | $m | [58.8](/filings/0001837240-24-000232.md) | [64.1](/filings/0001837240-25-000044.md) | [30.2](/filings/0001837240-25-000152.md) | [55.0](/filings/0001837240-25-000263.md) | [96.4](/filings/0001837240-24-000232.md) | [81.0](/filings/0001837240-26-000009.md) | [111](/filings/0001837240-26-000024.md) | [112](/filings/0001837240-26-000043.md) | [119 d](/filings/0001837240-25-000278.md) | [133](/filings/0001837240-26-000009.md) | [150](/filings/0001837240-26-000024.md) | [161](/filings/0001837240-26-000043.md) |
| Research and development | $m | [45.8 d](/filings/0001837240-25-000278.md) | [42.1](/filings/0001837240-25-000044.md) | [46.5](/filings/0001837240-25-000152.md) | [44.7](/filings/0001837240-25-000263.md) | [40.1 d](/filings/0001837240-25-000278.md) | [43.3](/filings/0001837240-26-000009.md) | [58.0](/filings/0001837240-26-000024.md) | [49.7](/filings/0001837240-26-000043.md) | [65.0 d](/filings/0001837240-25-000278.md) | [43.0](/filings/0001837240-26-000009.md) | [51.3](/filings/0001837240-26-000024.md) | [43.8](/filings/0001837240-26-000043.md) |
| Selling, general and administrative | $m | [66.9 d](/filings/0001837240-25-000278.md) | [47.0](/filings/0001837240-25-000044.md) | [48.7](/filings/0001837240-25-000152.md) | [47.9](/filings/0001837240-25-000263.md) | [45.4 d](/filings/0001837240-25-000278.md) | [60.7](/filings/0001837240-26-000009.md) | [73.3](/filings/0001837240-26-000024.md) | [71.6](/filings/0001837240-26-000043.md) | [93.2 d](/filings/0001837240-25-000278.md) | [81.2](/filings/0001837240-26-000009.md) | [92.6](/filings/0001837240-26-000024.md) | [84.2](/filings/0001837240-26-000043.md) |
| Operating income | $m | [(53.9)](/filings/0001837240-24-000232.md) | [(25.1)](/filings/0001837240-25-000044.md) | [(64.9)](/filings/0001837240-25-000152.md) | [(37.6)](/filings/0001837240-25-000263.md) | [10.9](/filings/0001837240-24-000232.md) | [(23.0)](/filings/0001837240-26-000009.md) | [(20.5)](/filings/0001837240-26-000024.md) | [(25.8)](/filings/0001837240-26-000043.md) | [(45.8) d](/filings/0001837240-25-000278.md) | [6.5](/filings/0001837240-26-000009.md) | [6.1](/filings/0001837240-26-000024.md) | [32.9](/filings/0001837240-26-000043.md) |
| Income tax | $m | [(4.9)](/filings/0001837240-24-000232.md) | [0.2](/filings/0001837240-25-000044.md) | [(0.3)](/filings/0001837240-25-000152.md) | [0.2](/filings/0001837240-25-000263.md) | [4.1](/filings/0001837240-24-000232.md) | [0.2](/filings/0001837240-26-000009.md) | [(1.4)](/filings/0001837240-26-000024.md) | [0.0](/filings/0001837240-26-000043.md) | [(0.4) d](/filings/0001837240-25-000278.md) | [0.6](/filings/0001837240-26-000009.md) | [0.6](/filings/0001837240-26-000024.md) | [(1.1)](/filings/0001837240-26-000043.md) |
| Net income | $m | [(6.2)](/filings/0001837240-24-000232.md) | [(2.8)](/filings/0001837240-25-000044.md) | [(8.8)](/filings/0001837240-25-000152.md) | [(4.7)](/filings/0001837240-25-000263.md) | [2.8](/filings/0001837240-24-000232.md) | [(3.2)](/filings/0001837240-26-000009.md) | [(1.8)](/filings/0001837240-26-000024.md) | [(3.9)](/filings/0001837240-26-000043.md) | [(8.0) d](/filings/0001837240-25-000278.md) | [2.6](/filings/0001837240-26-000009.md) | [2.0](/filings/0001837240-26-000024.md) | [11.7](/filings/0001837240-26-000043.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0001837240-24-000232.md) | [(0.03)](/filings/0001837240-25-000044.md) | [(0.09)](/filings/0001837240-25-000152.md) | [(0.05)](/filings/0001837240-25-000263.md) | [0.03](/filings/0001837240-24-000232.md) | [(0.03)](/filings/0001837240-26-000009.md) | [(0.02)](/filings/0001837240-26-000024.md) | [(0.04)](/filings/0001837240-26-000043.md) | not reported | [0.02](/filings/0001837240-26-000009.md) | [0.01](/filings/0001837240-26-000024.md) | [0.09](/filings/0001837240-26-000043.md) |
| Basic EPS | $ per share | [(0.08)](/filings/0001837240-24-000232.md) | [(0.03)](/filings/0001837240-25-000044.md) | [(0.09)](/filings/0001837240-25-000152.md) | [(0.05)](/filings/0001837240-25-000263.md) | [0.03](/filings/0001837240-24-000232.md) | [(0.03)](/filings/0001837240-26-000009.md) | [(0.02)](/filings/0001837240-26-000024.md) | [(0.04)](/filings/0001837240-26-000043.md) | not reported | [0.02](/filings/0001837240-26-000009.md) | [0.02](/filings/0001837240-26-000024.md) | [0.09](/filings/0001837240-26-000043.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [259](/filings/0001837240-25-000278.md) | [486](/filings/0001837240-25-000044.md) | [901](/filings/0001837240-25-000152.md) | [870](/filings/0001837240-25-000263.md) | [727](/filings/0001837240-25-000278.md) | [903](/filings/0001837240-26-000009.md) | [955](/filings/0001837240-26-000024.md) | [778](/filings/0001837240-26-000043.md) | [1,245](/filings/0001837240-26-000043.md) | [1,819](/filings/0001837240-26-000009.md) | [2,009](/filings/0001837240-26-000024.md) | [1,746](/filings/0001837240-26-000043.md) |
| Current assets | $m | [992](/filings/0001837240-24-000232.md) | [1,251](/filings/0001837240-24-000226.md) | [1,449](/filings/0001837240-24-000228.md) | [1,313](/filings/0001837240-24-000230.md) | [1,356](/filings/0001837240-25-000278.md) | [1,458](/filings/0001837240-25-000044.md) | [1,498](/filings/0001837240-25-000152.md) | [1,426](/filings/0001837240-25-000263.md) | [1,885](/filings/0001837240-26-000043.md) | [2,458](/filings/0001837240-26-000009.md) | [2,922](/filings/0001837240-26-000024.md) | [2,858](/filings/0001837240-26-000043.md) |
| Total assets | $m | [1,051](/filings/0001837240-24-000232.md) | [1,316](/filings/0001837240-24-000226.md) | [1,553](/filings/0001837240-24-000228.md) | [1,500](/filings/0001837240-24-000230.md) | [1,579](/filings/0001837240-25-000278.md) | [1,716](/filings/0001837240-25-000044.md) | [1,964](/filings/0001837240-25-000152.md) | [1,827](/filings/0001837240-25-000263.md) | [2,396](/filings/0001837240-26-000043.md) | [2,994](/filings/0001837240-26-000009.md) | [3,495](/filings/0001837240-26-000024.md) | [3,524](/filings/0001837240-26-000043.md) |
| Current liabilities | $m | [1,025](/filings/0001837240-24-000232.md) | [1,096](/filings/0001837240-24-000226.md) | [1,076](/filings/0001837240-24-000228.md) | [1,023](/filings/0001837240-24-000230.md) | [1,017](/filings/0001837240-25-000278.md) | [1,197](/filings/0001837240-25-000044.md) | [1,473](/filings/0001837240-25-000152.md) | [1,317](/filings/0001837240-25-000263.md) | [1,729](/filings/0001837240-26-000043.md) | [1,784](/filings/0001837240-26-000009.md) | [2,022](/filings/0001837240-26-000024.md) | [2,147](/filings/0001837240-26-000043.md) |
| Total liabilities | $m | [1,053](/filings/0001837240-24-000232.md) | [1,150](/filings/0001837240-24-000226.md) | [1,159](/filings/0001837240-24-000228.md) | [1,154](/filings/0001837240-24-000230.md) | [1,188](/filings/0001837240-25-000278.md) | [1,322](/filings/0001837240-25-000044.md) | [1,543](/filings/0001837240-25-000152.md) | [1,384](/filings/0001837240-25-000263.md) | [1,918](/filings/0001837240-26-000043.md) | [2,034](/filings/0001837240-26-000009.md) | [2,468](/filings/0001837240-26-000024.md) | [2,390](/filings/0001837240-26-000043.md) |
| Shareholders' equity | $m | [0.1](/filings/0001837240-24-000232.md) | [(57.1)](/filings/0001837240-24-000226.md) | [197](/filings/0001837240-24-000228.md) | [197](/filings/0001837240-24-000230.md) | [197](/filings/0001837240-25-000278.md) | [197](/filings/0001837240-25-000044.md) | [205](/filings/0001837240-25-000152.md) | [211](/filings/0001837240-25-000263.md) | [220](/filings/0001837240-26-000043.md) | [664](/filings/0001837240-26-000009.md) | [686](/filings/0001837240-26-000024.md) | [709](/filings/0001837240-26-000043.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [44.5 d](/filings/0001837240-25-000278.md) | [(30.2)](/filings/0001837240-25-000044.md) | [21.1 d](/filings/0001837240-25-000152.md) | [50.4 d](/filings/0001837240-25-000263.md) | [(99.4) d](/filings/0001837240-25-000278.md) | [205](/filings/0001837240-26-000009.md) | [270 d](/filings/0001837240-26-000024.md) | [(197) d](/filings/0001837240-26-000043.md) | [589 d](/filings/0001837240-25-000278.md) | [192](/filings/0001837240-26-000009.md) | [261 d](/filings/0001837240-26-000024.md) | [(147) d](/filings/0001837240-26-000043.md) |
| Capital expenditure | $m | [(4.7) d](/filings/0001837240-24-000232.md) | [2.2](/filings/0001837240-25-000044.md) | [2.5 d](/filings/0001837240-24-000228.md) | [16.8 d](/filings/0001837240-24-000230.md) | [20.7 d](/filings/0001837240-24-000232.md) | [7.4](/filings/0001837240-25-000044.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-24) | Q2 FY2023 (2023-03-25) | Q3 FY2023 (2023-06-24) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [58.2](/filings/0001837240-24-000226.md) | [60.5](/filings/0001837240-24-000228.md) | [61.8](/filings/0001837240-24-000230.md) | [83.3](/filings/0001837240-25-000044.md) | [93.0](/filings/0001837240-25-000152.md) | [102](/filings/0001837240-25-000263.md) | [106](/filings/0001837240-26-000009.md) | [108](/filings/0001837240-26-000024.md) | [109](/filings/0001837240-26-000043.md) | [128](/filings/0001837240-26-000009.md) | [134](/filings/0001837240-26-000024.md) | [133](/filings/0001837240-26-000043.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.